CRL
NYSECHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Health Care, Life Sciences Tools & Services
$267.49
close 7 Aug 2026
+79.61%
52-week change
$12.77B
market cap
$144.26
$268.00
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||||||||||||
| Revenue | $4.00B | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.30B | $1.17B | $1.13B | $1.14B | $1.13B | $1.17B | $1.30B |
| Cost of revenue | — | — | — | — | — | — | — | — | — | $289.67M | $277.03M | $263.98M | $266.42M | $272.75M | $257.71M | $267.97M | $252.96M | $255.68M | $252.94M |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SG&A | $762.04M | $743.07M | $751.00M | $747.86M | $665.10M | $619.92M | $528.94M | $517.62M | $443.85M | $371.27M | $364.71M | $300.41M | $269.03M | $225.70M | $208.25M | $198.65M | $232.49M | $227.66M | $223.94M |
| Operating income | $90.14M | $25.16M | $227.35M | $617.26M | $650.98M | $589.86M | $432.73M | $351.15M | $331.38M | $288.28M | $237.55M | $206.45M | $177.67M | $151.40M | $165.77M | $174.31M | -$298.51M | $169.61M | -$451.84M |
| Interest expense | $106.26M | $107.03M | $126.29M | $136.71M | $59.29M | $73.91M | $86.43M | $60.88M | $63.77M | $29.78M | $27.71M | $15.07M | $11.95M | $20.97M | $33.34M | $42.59M | $35.28M | $21.68M | $22.34M |
| Tax expense | $52.63M | $42.66M | $67.82M | $100.91M | $130.38M | $81.87M | $81.81M | $50.02M | $54.46M | $171.37M | $66.84M | $43.39M | $47.67M | $32.91M | $27.63M | $17.14M | $23.00K | $40.35M | $57.03M |
| Net income | -$238.46M | -$144.34M | $22.20M | $474.62M | $486.23M | $390.98M | $364.30M | $252.02M | $226.37M | $123.36M | $154.77M | $149.31M | $126.70M | $102.83M | $97.87M | $109.98M | -$342.12M | $112.60M | -$524.51M |
| Diluted EPS | -$4.80 | -$2.91 | $0.2000 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | $2.12 | $2.01 | $2.14 | -$5.38 | $1.74 | -$7.80 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 2.25% | 0.63% | 5.61% | 14.95% | 16.37% | 16.66% | 14.80% | 13.40% | 14.62% | 15.52% | 14.13% | 15.14% | 13.69% | 12.99% | 14.68% | 15.25% | -26.34% | 14.48% | -34.88% |
| Net margin | -5.96% | -3.59% | 0.55% | 11.49% | 12.23% | 11.04% | 12.46% | 9.61% | 9.99% | 6.64% | 9.20% | 10.95% | 9.76% | 8.82% | 8.66% | 9.62% | -30.18% | 9.61% | -40.49% |
filed 5 Aug 2026